DE69731003D1 - Blutzuckersenkende und lipidsenkende verbindungen - Google Patents

Blutzuckersenkende und lipidsenkende verbindungen

Info

Publication number
DE69731003D1
DE69731003D1 DE69731003T DE69731003T DE69731003D1 DE 69731003 D1 DE69731003 D1 DE 69731003D1 DE 69731003 T DE69731003 T DE 69731003T DE 69731003 T DE69731003 T DE 69731003T DE 69731003 D1 DE69731003 D1 DE 69731003D1
Authority
DE
Germany
Prior art keywords
lowering
compounds
lipid
glucose
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69731003T
Other languages
English (en)
Inventor
J Dominianni
H Gritton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69731003D1 publication Critical patent/DE69731003D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DE69731003T 1996-07-01 1997-06-30 Blutzuckersenkende und lipidsenkende verbindungen Expired - Lifetime DE69731003D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2101796P 1996-07-01 1996-07-01
PCT/US1997/011514 WO1998000403A1 (en) 1996-07-01 1997-06-30 Hypoglycemic and hypolipidemic compounds

Publications (1)

Publication Number Publication Date
DE69731003D1 true DE69731003D1 (de) 2004-11-04

Family

ID=21801860

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731003T Expired - Lifetime DE69731003D1 (de) 1996-07-01 1997-06-30 Blutzuckersenkende und lipidsenkende verbindungen

Country Status (10)

Country Link
US (1) US6121282A (de)
EP (1) EP1019378B1 (de)
JP (1) JP2000515501A (de)
AT (1) ATE277907T1 (de)
AU (1) AU3513497A (de)
CA (1) CA2259431A1 (de)
DE (1) DE69731003D1 (de)
IL (1) IL121203A (de)
WO (1) WO1998000403A1 (de)
ZA (1) ZA975867B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414002B1 (en) 1999-09-22 2002-07-02 Bristol-Myers Squibb Company Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
TWI260321B (en) 1999-09-22 2006-08-21 Bristol Myers Squibb Co Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
CN1215059C (zh) * 1999-12-03 2005-08-17 京都药品工业株式会社 新的杂环化合物及其盐和它们的医药用途
US7187947B1 (en) 2000-03-28 2007-03-06 Affinity Labs, Llc System and method for communicating selected information to an electronic device
PL367676A1 (en) * 2001-05-29 2005-03-07 Kyoto Pharmaceutical Industries, Ltd. Novel heterocyclic derivatives and medicinal use thereof
CZ20033450A3 (cs) 2001-05-29 2004-05-12 Kyotoápharmaceuticaláindustriesźáltd Heterocyklická sloučenina a její lékařské použití
JPWO2002102780A1 (ja) * 2001-06-18 2004-09-30 小野薬品工業株式会社 テトラヒドロキノリン誘導体化合物およびその化合物を有効成分として含有する薬剤
EP2432190A3 (de) 2001-06-27 2014-02-19 SKKY Incorporated Verbesserte Medienablieferungsplattform
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
PL374860A1 (en) 2002-07-09 2005-11-14 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
EP1630152A4 (de) * 2003-05-30 2009-09-23 Takeda Pharmaceutical Verbindung mit kondensiertem ring
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
KR100799802B1 (ko) 2004-02-04 2008-01-31 화이자 프로덕츠 인크. 치환된 퀴놀린 화합물
US20080186971A1 (en) * 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
WO2012033195A1 (ja) * 2010-09-10 2012-03-15 京都薬品工業株式会社 複素環化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988720A (en) * 1985-05-28 1991-01-29 Beecham Group P.L.C. Novel treatment of hyperglycaemia
US4999363A (en) * 1988-06-09 1991-03-12 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
AU6368090A (en) * 1989-10-03 1991-04-11 Warner-Lambert Company Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
WO1992021342A1 (en) * 1991-06-07 1992-12-10 Otsuka Pharmaceutical Co., Ltd. Antidiabetic
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
WO1993023409A1 (en) * 1992-05-21 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivative
US5236934A (en) * 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
GB9311661D0 (en) * 1993-06-05 1993-07-21 Smithkline Beecham Plc Novel compounds
US5591862A (en) * 1993-06-11 1997-01-07 Takeda Chemical Industries, Ltd. Tetrazole derivatives, their production and use
WO1995009001A1 (en) * 1993-09-30 1995-04-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5571792A (en) * 1994-06-30 1996-11-05 Warner-Lambert Company Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
US5616819A (en) * 1995-08-28 1997-04-01 Laroche Industries Inc. Process for preparing fluorinated aliphatic compounds
US5885327A (en) * 1995-09-12 1999-03-23 Henkel Corporation Process for the recovery of gold
DE19535243A1 (de) * 1995-09-22 1997-03-27 Bayer Ag Neue Zwischenprodukte für die Synthese von Bisphosphinverbindungen

Also Published As

Publication number Publication date
EP1019378B1 (de) 2004-09-29
US6121282A (en) 2000-09-19
ZA975867B (en) 1999-01-04
EP1019378A4 (de) 2001-09-26
IL121203A0 (en) 1997-11-20
IL121203A (en) 2001-04-30
JP2000515501A (ja) 2000-11-21
AU3513497A (en) 1998-01-21
ATE277907T1 (de) 2004-10-15
WO1998000403A1 (en) 1998-01-08
CA2259431A1 (en) 1998-01-08
EP1019378A1 (de) 2000-07-19

Similar Documents

Publication Publication Date Title
DE69731003D1 (de) Blutzuckersenkende und lipidsenkende verbindungen
CO4940465A1 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3- il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
ATE234092T1 (de) 2-alkylpyrrolidine
DK2018874T3 (da) Farmaceutiske sammensætninger til forebyggelse og behandling af lidelser i centralnervesystemet indeholdende en nikotinisk agonist og en acetylcholinesteraseinhibitor
PT842934E (pt) Agonistas de 5-ht1f
SE9704546D0 (sv) Novel compounds
AP9701041A0 (en) Pyridylpyrrole compounds.
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
PT934065E (pt) Compostos farmaceuticos
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
ATE220688T1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
DE69729183T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
HUP9700598A2 (hu) Eljárás hasnyálmirigy-gyulladás megelőzésére és kezelésére alkalmas gyógyszerkészítmény előállítására
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
NO20000519L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
DE69626544D1 (de) Arzneistoffe
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
PT871446E (pt) Utilizacao de eliprodil para o fabrico de um medicamento destinado ao tratamento de perturbacoes isquemicas da retina ou do nervo optico
ID25478A (id) Agonis 5-ht1f
HUP9701618A2 (hu) Tramadolt és valamely kálciumcsatorna antagonistát tartalmazó gyógyászati készítmény

Legal Events

Date Code Title Description
8332 No legal effect for de